Immune Targeting

Bioneer offers evaluation of compounds using mainly three cell systems 1) Primary dendritic cells (human and murine) 2) Peripheral blood mononuclear cells (PBMCs) and 3) cell line based models. We provide services in our model systems in the discovery process (mainly evaluation of mechanism of action and immune modulation and suppression of specific inflammatory responses) as well as activities involved in the development process (mainly evaluation of safety of IV administered drugs, and assessment of potency).

For more information please follow the links below.

Design ”Proof of Principle” study

					Immune modulation
		Evaluate mechanism of action	Evaluation of safety	Assessment of potency	General responses	Th1/Th17-responses	Th2-responses
	Dendritic cell models	X		X	X	X	X
	PBMC models	X	X	X	X	X
	Cell line models	X		X	X